ContractAbivax S.A. • September 29th, 2023 • Pharmaceutical preparations
Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant treats as private or confidential.
SUBSCRIPTION AGREEMENT By and between Abivax S.A. as Issuer and Kreos Capital VII (UK) Limited Kreos Capital VII Aggregator SCSp Claret European Specialty Lending Company III, S.à r.l. Claret European Growth Capital Fund III SCSp As SubscribersSubscription Agreement • September 29th, 2023 • Abivax S.A. • Pharmaceutical preparations
This subscription agreement (hereinafter referred to as the “Subscription Agreement”) is entered into on 20 August 2023, by and between:
ContractDrug Discovery Services Agreement • September 29th, 2023 • Abivax S.A. • Pharmaceutical preparations
Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant treats as private or confidential.
ContractAbivax S.A. • September 29th, 2023 • Pharmaceutical preparations
Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant treats as private or confidential.
ContractAbivax S.A. • September 29th, 2023 • Pharmaceutical preparations
Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant treats as private or confidential.
ContractAbivax S.A. • September 29th, 2023 • Pharmaceutical preparations
Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant treats as private or confidential.
ContractAbivax S.A. • September 29th, 2023 • Pharmaceutical preparations
Certain confidential information contained in this document, marked by [***], has been omitted because it is both (i) not material and (ii) is the type that the registrant treats as private or confidential.
ContractAbivax S.A. • September 29th, 2023 • Pharmaceutical preparations
Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant treats as private or confidential.
ContractAbivax S.A. • September 29th, 2023 • Pharmaceutical preparations
Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant treats as private or confidential.
